Back to search

Amphotericin B lipid complex therapy of experimental fungal infections in mice

Data up to Jan 2025

Published1991
Citations160
References26

Total Citations Per Year

Abstract

References (26)

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12

1938 • 19,183 citations

A simple method of estimating 50 per cent end points

1938 • 8,381 citations

Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

1985 • 412 citations

Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin B

1983 • 300 citations

Unusual lipid structures selectively reduce the toxicity of amphotericin B.

1988 • 225 citations

Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.

1987 • 217 citations

Treatment of Murine Cryptococcosis with Liposome-Associated Amphotericin B

1982 • 205 citations

Treatment of systemic fungal infections with liposomal amphotericin B.

1989 • 177 citations

Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B

1987 • 173 citations

Itraconazole, a new triazole that is orally active in aspergillosis

1984 • 160 citations

Amphotericin B in Liposomes: A Novel Therapy for Histoplasmosis1

1982 • 157 citations

Fungal Infections in Patients with AIDS and AIDS-related Complex

1986 • 148 citations

Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections

1988 • 134 citations

Liposome-Encapsulated Amphotericin B for Treatment of Disseminated Candidiasis in Neutropenic Mice

1984 • 126 citations

An Emulsion Formulation of Amphotericin B Improves the Therapeutic Index When Treating Systemic Murine Candidiasis

1988 • 105 citations

Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice

1989 • 101 citations

Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice

1984 • 97 citations

Treatment of Experimental Invasive Aspergillosis with Novel Amphotericin B/Cholesterol-Sulfate Complexes

1989 • 92 citations

Treatment of invasive aspergillus sinusitis with liposomal‐amphotericin B

1987 • 70 citations

Liposome-Encapsulated Amphotericin B: A Promising New Treatment for Disseminated Fungal Infections

1988 • 59 citations

Treatment of experimental murine candidiasis with liposome-associated amphotericin B

1984 • 37 citations

Liposomal amphotericin B for treatment of pulmonary aspergillosis in a heart transplant patient.

1990 • 32 citations

Treatment of murine histoplasmosis with UK 49,858 (fluconazole).

1986 • 32 citations

Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice

1987 • 29 citations

Effect of attachment of anticandidal antibody to the surfaces of liposomes encapsulating amphotericin B in the treatment of murine candidiasis

1989 • 27 citations

Variation in the lethal response in mice to yeast-like and pseudohyphal forms of Candida albicans

1975 • 24 citations

Cited By (0)

Loading...
Amphotericin B lipid complex therapy of experimental fungal infections in mice (1991) – Antimicrobial Agents and Chemotherapy | Metascience Observatory Explorer